| Preface | 5 |
|---|
| Contents | 11 |
|---|
| Abbreviations | 19 |
|---|
| Session A Novel approach on synthetic method | 21 |
|---|
| Orthogonal ligation of free peptides | 22 |
| Solid phase synthesis of peptide aldehydes | 27 |
| Investigation of enzyme activity and inhibition in the interior of novel solid supports | 33 |
| Immobilization of a-Chymotrypsin on zeolite for peptide synthesis in organic solvent | 40 |
| Preparation of a peptide thioester using a fluoren-9-ylmethoxycarbonyl solid-phase method | 45 |
| Application of DEPBT for the synthesis of N-protected peptide alcohols | 49 |
| Decomposition of amino acid cupric complex by using tetrahydrothiazole-2-thione for preparation ofN a-Boc-Ne-Fmoc-L-Lysine | 52 |
| Two-step selective formation of three disulfide bridges in the synthesis of d-Gonotoxin PVIA | 55 |
| Session B Structure, folding and conformation analysis De novo design of peptide | 55 |
|---|
| 59 | 55 |
|---|
| Design, synthesis and NMR structure of a rigid cyclic peptide template | 60 |
| Automated docking of Sch68631 with HCV NS3 protease | 65 |
| Molecular modeling of the three-dimensional structure of the human interleukin-11 | 68 |
| Designing ß-hairpin forming short peptide | 72 |
| Anti-tumor activities of papavor somniferum pollen peptides | 76 |
| Structural investigation of two pollen peptides by 2 D homonuclear NMR spectroscopy | 79 |
| A comparison of three heuristic algorithms for molecular docking | 82 |
| Aggregation of a calmodulin-binding peptide | 86 |
| Session C Neuro/Endocrino/Bioactive peptide | 90 |
|---|
| Neuropeptide AVP(4-8) playing an indirect neurotrophic role | 91 |
| Potent bradykinin antagonists having medical potential | 93 |
| Understanding the chemistry and biology of rodent relaxin: Role of the C-peptide | 97 |
| Purification and characterization of a new conotoxin from the venom ofConus betulinus | 102 |
| Synthesis and biological activity of human calcitonin analogs | 105 |
| Enhanced expression of CNDF mRNA in rat brain by administration of AVP(4-8) | 108 |
| The synthesis and opioid activities of nociceptin and its fragments | 111 |
| The effect of Glu position change on the opioid activity of deltorphin II | 114 |
| Isolation and purification of a series of peptides from Panax notoginseng | 118 |
| Study of the relationship between structure and function of HIV-1 gp 41 N terminus fusion peptide | 120 |
| Hypotensive activities of nociceptin and its fragments | 124 |
| The design and synthesis of endomorphins and their analogues | 128 |
| Neuronal apoptosis induced by ß-amyloid peptides in vitro | 132 |
| Studies on the spin-labeling technique on deltorphin II and its analogues | 135 |
| Design and synthesis of salmon calcitonin and its analogues | 140 |
| Studies on the synthesis and antithrombosis activity of two peptides derived from the molecular-binding site of fibrinogen | 142 |
| Synthesis and expression of w-conotoxin MVIIA | 145 |
| Session D Peptide vaccines/Immunology/Virus | 150 |
|---|
| Studies on the synthetic peptide vaccines against schistosomiasis | 151 |
| Studies on the anti-schistosomal synthetic peptide vaccine: Prediction and synthesis of antigenic peptides of Schistosoma paramyosin | 154 |
| Construction and expression of a recombinant antibody targeted plasminogen activator | 156 |
| Chemical conjugation between haemophilus influenzae type b (hib) polysaccharide and proteins | 159 |
| Synthesis of human inhi
|